Assenagon Asset Management S.A. boosted its stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 1.1% during the first quarter, Holdings Channel.com reports. The firm owned 241,206 shares of the biopharmaceutical company’s stock after …